EVOLVE-HBV (Evaluation of Vukuzazi LiVEr disease - Hepatitis B): A retrospective serosurvey of Hepatitis B Virus (HBV) infection, exposure, and vaccine-mediated immunity using archived samples from the Vukuzazi Study (2018-2020).

South Africa, 2018 - 2020

Reference ID

AHRI.EVOLVE.HBV

Producer(s)

Siyabonga Nxumalo, Lusanda Mazibuko, Nompumelelo Mkwanazi, Prof Philippa C Matthews, Prof Collins Iwuji, Dr Motswedi Anderson, Kathy Baisley, Gregory Ording-Jespersen, Mark Siedner, Emily Wong, Willem Hanekom, Vukuzazi Field Team, Sample Processing Unit, Khanyi Msomi, Theresa Smit, Dickman Gareta,

Metadata

Documentation in PDF DDI/XML JSON

Created on

Jul 14, 2026

Last modified

Jul 14, 2026

Page views

673

Downloads

TB care cascade status (tbcascade)

Data file: vk_evolve

Overview

Valid: 2076

Invalid: 124

Type: Discrete

Decimal: 0

Width: 12

Range: 0 - 2

Format: Numeric

Questions and instructions

Categories

Value	Category	Cases
0	No active TB	2051	98.8%
1	Bacteriologically confirmed TB not on treatment	17	0.8%
2	On TB treatment (with/without bact confirm)	8	0.4%
Sysmiss		124

Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.

Back to Catalog